Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CAR-T Cell Immunotherapies for Cancer Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 CD19
1.2.3 BCMA
1.2.4 EPCAM
1.3 Market by Application
1.3.1 Global CAR-T Cell Immunotherapies for Cancer Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hematological Cancer
1.3.3 Solid Tumor
1.3.4 Other Oncological Disorders
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CAR-T Cell Immunotherapies for Cancer Market Perspective (2018-2033)
2.2 CAR-T Cell Immunotherapies for Cancer Growth Trends by Region
2.2.1 Global CAR-T Cell Immunotherapies for Cancer Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 CAR-T Cell Immunotherapies for Cancer Historic Market Size by Region (2018-2023)
2.2.3 CAR-T Cell Immunotherapies for Cancer Forecasted Market Size by Region (2024-2033)
2.3 CAR-T Cell Immunotherapies for Cancer Market Dynamics
2.3.1 CAR-T Cell Immunotherapies for Cancer Industry Trends
2.3.2 CAR-T Cell Immunotherapies for Cancer Market Drivers
2.3.3 CAR-T Cell Immunotherapies for Cancer Market Challenges
2.3.4 CAR-T Cell Immunotherapies for Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CAR-T Cell Immunotherapies for Cancer Players by Revenue
3.1.1 Global Top CAR-T Cell Immunotherapies for Cancer Players by Revenue (2018-2023)
3.1.2 Global CAR-T Cell Immunotherapies for Cancer Revenue Market Share by Players (2018-2023)
3.2 Global CAR-T Cell Immunotherapies for Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CAR-T Cell Immunotherapies for Cancer Revenue
3.4 Global CAR-T Cell Immunotherapies for Cancer Market Concentration Ratio
3.4.1 Global CAR-T Cell Immunotherapies for Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CAR-T Cell Immunotherapies for Cancer Revenue in 2022
3.5 CAR-T Cell Immunotherapies for Cancer Key Players Head office and Area Served
3.6 Key Players CAR-T Cell Immunotherapies for Cancer Product Solution and Service
3.7 Date of Enter into CAR-T Cell Immunotherapies for Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CAR-T Cell Immunotherapies for Cancer Breakdown Data by Type
4.1 Global CAR-T Cell Immunotherapies for Cancer Historic Market Size by Type (2018-2023)
4.2 Global CAR-T Cell Immunotherapies for Cancer Forecasted Market Size by Type (2024-2033)
5 CAR-T Cell Immunotherapies for Cancer Breakdown Data by Application
5.1 Global CAR-T Cell Immunotherapies for Cancer Historic Market Size by Application (2018-2023)
5.2 Global CAR-T Cell Immunotherapies for Cancer Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America CAR-T Cell Immunotherapies for Cancer Market Size (2018-2033)
6.2 North America CAR-T Cell Immunotherapies for Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America CAR-T Cell Immunotherapies for Cancer Market Size by Country (2018-2023)
6.4 North America CAR-T Cell Immunotherapies for Cancer Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CAR-T Cell Immunotherapies for Cancer Market Size (2018-2033)
7.2 Europe CAR-T Cell Immunotherapies for Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe CAR-T Cell Immunotherapies for Cancer Market Size by Country (2018-2023)
7.4 Europe CAR-T Cell Immunotherapies for Cancer Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CAR-T Cell Immunotherapies for Cancer Market Size (2018-2033)
8.2 Asia-Pacific CAR-T Cell Immunotherapies for Cancer Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific CAR-T Cell Immunotherapies for Cancer Market Size by Region (2018-2023)
8.4 Asia-Pacific CAR-T Cell Immunotherapies for Cancer Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CAR-T Cell Immunotherapies for Cancer Market Size (2018-2033)
9.2 Latin America CAR-T Cell Immunotherapies for Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America CAR-T Cell Immunotherapies for Cancer Market Size by Country (2018-2023)
9.4 Latin America CAR-T Cell Immunotherapies for Cancer Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CAR-T Cell Immunotherapies for Cancer Market Size (2018-2033)
10.2 Middle East & Africa CAR-T Cell Immunotherapies for Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa CAR-T Cell Immunotherapies for Cancer Market Size by Country (2018-2023)
10.4 Middle East & Africa CAR-T Cell Immunotherapies for Cancer Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 NOVARTIS
11.1.1 NOVARTIS Company Detail
11.1.2 NOVARTIS Business Overview
11.1.3 NOVARTIS CAR-T Cell Immunotherapies for Cancer Introduction
11.1.4 NOVARTIS Revenue in CAR-T Cell Immunotherapies for Cancer Business (2018-2023)
11.1.5 NOVARTIS Recent Development
11.2 Penn
11.2.1 Penn Company Detail
11.2.2 Penn Business Overview
11.2.3 Penn CAR-T Cell Immunotherapies for Cancer Introduction
11.2.4 Penn Revenue in CAR-T Cell Immunotherapies for Cancer Business (2018-2023)
11.2.5 Penn Recent Development
11.3 Fosun Pharma
11.3.1 Fosun Pharma Company Detail
11.3.2 Fosun Pharma Business Overview
11.3.3 Fosun Pharma CAR-T Cell Immunotherapies for Cancer Introduction
11.3.4 Fosun Pharma Revenue in CAR-T Cell Immunotherapies for Cancer Business (2018-2023)
11.3.5 Fosun Pharma Recent Development
11.4 Celgene Corporation
11.4.1 Celgene Corporation Company Detail
11.4.2 Celgene Corporation Business Overview
11.4.3 Celgene Corporation CAR-T Cell Immunotherapies for Cancer Introduction
11.4.4 Celgene Corporation Revenue in CAR-T Cell Immunotherapies for Cancer Business (2018-2023)
11.4.5 Celgene Corporation Recent Development
11.5 Legend Biotech
11.5.1 Legend Biotech Company Detail
11.5.2 Legend Biotech Business Overview
11.5.3 Legend Biotech CAR-T Cell Immunotherapies for Cancer Introduction
11.5.4 Legend Biotech Revenue in CAR-T Cell Immunotherapies for Cancer Business (2018-2023)
11.5.5 Legend Biotech Recent Development
11.6 SHEBA
11.6.1 SHEBA Company Detail
11.6.2 SHEBA Business Overview
11.6.3 SHEBA CAR-T Cell Immunotherapies for Cancer Introduction
11.6.4 SHEBA Revenue in CAR-T Cell Immunotherapies for Cancer Business (2018-2023)
11.6.5 SHEBA Recent Development
11.7 JW Therapeutics
11.7.1 JW Therapeutics Company Detail
11.7.2 JW Therapeutics Business Overview
11.7.3 JW Therapeutics CAR-T Cell Immunotherapies for Cancer Introduction
11.7.4 JW Therapeutics Revenue in CAR-T Cell Immunotherapies for Cancer Business (2018-2023)
11.7.5 JW Therapeutics Recent Development
11.8 Protheragen
11.8.1 Protheragen Company Detail
11.8.2 Protheragen Business Overview
11.8.3 Protheragen CAR-T Cell Immunotherapies for Cancer Introduction
11.8.4 Protheragen Revenue in CAR-T Cell Immunotherapies for Cancer Business (2018-2023)
11.8.5 Protheragen Recent Development
11.9 EXUMA Biotechnology
11.9.1 EXUMA Biotechnology Company Detail
11.9.2 EXUMA Biotechnology Business Overview
11.9.3 EXUMA Biotechnology CAR-T Cell Immunotherapies for Cancer Introduction
11.9.4 EXUMA Biotechnology Revenue in CAR-T Cell Immunotherapies for Cancer Business (2018-2023)
11.9.5 EXUMA Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global CAR-T Cell Immunotherapies for Cancer Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of CD19
Table 3. Key Players of BCMA
Table 4. Key Players of EPCAM
Table 5. Global CAR-T Cell Immunotherapies for Cancer Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global CAR-T Cell Immunotherapies for Cancer Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global CAR-T Cell Immunotherapies for Cancer Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global CAR-T Cell Immunotherapies for Cancer Market Share by Region (2018-2023)
Table 9. Global CAR-T Cell Immunotherapies for Cancer Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global CAR-T Cell Immunotherapies for Cancer Market Share by Region (2024-2033)
Table 11. CAR-T Cell Immunotherapies for Cancer Market Trends
Table 12. CAR-T Cell Immunotherapies for Cancer Market Drivers
Table 13. CAR-T Cell Immunotherapies for Cancer Market Challenges
Table 14. CAR-T Cell Immunotherapies for Cancer Market Restraints
Table 15. Global CAR-T Cell Immunotherapies for Cancer Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global CAR-T Cell Immunotherapies for Cancer Market Share by Players (2018-2023)
Table 17. Global Top CAR-T Cell Immunotherapies for Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Cell Immunotherapies for Cancer as of 2022)
Table 18. Ranking of Global Top CAR-T Cell Immunotherapies for Cancer Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by CAR-T Cell Immunotherapies for Cancer Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players CAR-T Cell Immunotherapies for Cancer Product Solution and Service
Table 22. Date of Enter into CAR-T Cell Immunotherapies for Cancer Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global CAR-T Cell Immunotherapies for Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global CAR-T Cell Immunotherapies for Cancer Revenue Market Share by Type (2018-2023)
Table 26. Global CAR-T Cell Immunotherapies for Cancer Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global CAR-T Cell Immunotherapies for Cancer Revenue Market Share by Type (2024-2033)
Table 28. Global CAR-T Cell Immunotherapies for Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global CAR-T Cell Immunotherapies for Cancer Revenue Market Share by Application (2018-2023)
Table 30. Global CAR-T Cell Immunotherapies for Cancer Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global CAR-T Cell Immunotherapies for Cancer Revenue Market Share by Application (2024-2033)
Table 32. North America CAR-T Cell Immunotherapies for Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America CAR-T Cell Immunotherapies for Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America CAR-T Cell Immunotherapies for Cancer Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe CAR-T Cell Immunotherapies for Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe CAR-T Cell Immunotherapies for Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe CAR-T Cell Immunotherapies for Cancer Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific CAR-T Cell Immunotherapies for Cancer Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific CAR-T Cell Immunotherapies for Cancer Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific CAR-T Cell Immunotherapies for Cancer Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America CAR-T Cell Immunotherapies for Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America CAR-T Cell Immunotherapies for Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America CAR-T Cell Immunotherapies for Cancer Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa CAR-T Cell Immunotherapies for Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa CAR-T Cell Immunotherapies for Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa CAR-T Cell Immunotherapies for Cancer Market Size by Country (2024-2033) & (US$ Million)
Table 47. NOVARTIS Company Detail
Table 48. NOVARTIS Business Overview
Table 49. NOVARTIS CAR-T Cell Immunotherapies for Cancer Product
Table 50. NOVARTIS Revenue in CAR-T Cell Immunotherapies for Cancer Business (2018-2023) & (US$ Million)
Table 51. NOVARTIS Recent Development
Table 52. Penn Company Detail
Table 53. Penn Business Overview
Table 54. Penn CAR-T Cell Immunotherapies for Cancer Product
Table 55. Penn Revenue in CAR-T Cell Immunotherapies for Cancer Business (2018-2023) & (US$ Million)
Table 56. Penn Recent Development
Table 57. Fosun Pharma Company Detail
Table 58. Fosun Pharma Business Overview
Table 59. Fosun Pharma CAR-T Cell Immunotherapies for Cancer Product
Table 60. Fosun Pharma Revenue in CAR-T Cell Immunotherapies for Cancer Business (2018-2023) & (US$ Million)
Table 61. Fosun Pharma Recent Development
Table 62. Celgene Corporation Company Detail
Table 63. Celgene Corporation Business Overview
Table 64. Celgene Corporation CAR-T Cell Immunotherapies for Cancer Product
Table 65. Celgene Corporation Revenue in CAR-T Cell Immunotherapies for Cancer Business (2018-2023) & (US$ Million)
Table 66. Celgene Corporation Recent Development
Table 67. Legend Biotech Company Detail
Table 68. Legend Biotech Business Overview
Table 69. Legend Biotech CAR-T Cell Immunotherapies for Cancer Product
Table 70. Legend Biotech Revenue in CAR-T Cell Immunotherapies for Cancer Business (2018-2023) & (US$ Million)
Table 71. Legend Biotech Recent Development
Table 72. SHEBA Company Detail
Table 73. SHEBA Business Overview
Table 74. SHEBA CAR-T Cell Immunotherapies for Cancer Product
Table 75. SHEBA Revenue in CAR-T Cell Immunotherapies for Cancer Business (2018-2023) & (US$ Million)
Table 76. SHEBA Recent Development
Table 77. JW Therapeutics Company Detail
Table 78. JW Therapeutics Business Overview
Table 79. JW Therapeutics CAR-T Cell Immunotherapies for Cancer Product
Table 80. JW Therapeutics Revenue in CAR-T Cell Immunotherapies for Cancer Business (2018-2023) & (US$ Million)
Table 81. JW Therapeutics Recent Development
Table 82. Protheragen Company Detail
Table 83. Protheragen Business Overview
Table 84. Protheragen CAR-T Cell Immunotherapies for Cancer Product
Table 85. Protheragen Revenue in CAR-T Cell Immunotherapies for Cancer Business (2018-2023) & (US$ Million)
Table 86. Protheragen Recent Development
Table 87. EXUMA Biotechnology Company Detail
Table 88. EXUMA Biotechnology Business Overview
Table 89. EXUMA Biotechnology CAR-T Cell Immunotherapies for Cancer Product
Table 90. EXUMA Biotechnology Revenue in CAR-T Cell Immunotherapies for Cancer Business (2018-2023) & (US$ Million)
Table 91. EXUMA Biotechnology Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CAR-T Cell Immunotherapies for Cancer Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global CAR-T Cell Immunotherapies for Cancer Market Share by Type: 2022 VS 2033
Figure 3. CD19 Features
Figure 4. BCMA Features
Figure 5. EPCAM Features
Figure 6. Global CAR-T Cell Immunotherapies for Cancer Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global CAR-T Cell Immunotherapies for Cancer Market Share by Application: 2022 VS 2033
Figure 8. Hematological Cancer Case Studies
Figure 9. Solid Tumor Case Studies
Figure 10. Other Oncological Disorders Case Studies
Figure 11. CAR-T Cell Immunotherapies for Cancer Report Years Considered
Figure 12. Global CAR-T Cell Immunotherapies for Cancer Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global CAR-T Cell Immunotherapies for Cancer Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global CAR-T Cell Immunotherapies for Cancer Market Share by Region: 2022 VS 2033
Figure 15. Global CAR-T Cell Immunotherapies for Cancer Market Share by Players in 2022
Figure 16. Global Top CAR-T Cell Immunotherapies for Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Cell Immunotherapies for Cancer as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by CAR-T Cell Immunotherapies for Cancer Revenue in 2022
Figure 18. North America CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America CAR-T Cell Immunotherapies for Cancer Market Share by Country (2018-2033)
Figure 20. United States CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe CAR-T Cell Immunotherapies for Cancer Market Share by Country (2018-2033)
Figure 24. Germany CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific CAR-T Cell Immunotherapies for Cancer Market Share by Region (2018-2033)
Figure 32. China CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America CAR-T Cell Immunotherapies for Cancer Market Share by Country (2018-2033)
Figure 40. Mexico CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa CAR-T Cell Immunotherapies for Cancer Market Share by Country (2018-2033)
Figure 44. Turkey CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. NOVARTIS Revenue Growth Rate in CAR-T Cell Immunotherapies for Cancer Business (2018-2023)
Figure 47. Penn Revenue Growth Rate in CAR-T Cell Immunotherapies for Cancer Business (2018-2023)
Figure 48. Fosun Pharma Revenue Growth Rate in CAR-T Cell Immunotherapies for Cancer Business (2018-2023)
Figure 49. Celgene Corporation Revenue Growth Rate in CAR-T Cell Immunotherapies for Cancer Business (2018-2023)
Figure 50. Legend Biotech Revenue Growth Rate in CAR-T Cell Immunotherapies for Cancer Business (2018-2023)
Figure 51. SHEBA Revenue Growth Rate in CAR-T Cell Immunotherapies for Cancer Business (2018-2023)
Figure 52. JW Therapeutics Revenue Growth Rate in CAR-T Cell Immunotherapies for Cancer Business (2018-2023)
Figure 53. Protheragen Revenue Growth Rate in CAR-T Cell Immunotherapies for Cancer Business (2018-2023)
Figure 54. EXUMA Biotechnology Revenue Growth Rate in CAR-T Cell Immunotherapies for Cancer Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed